Cytochroma Inc. logo
Exited company

Cytochroma Inc.

Details
Region
Ontario
Industry sector
Biotechnology
Investment year
2002
Fund
Healthcare Venture Fund
Learn more
Lead
Ela Borenstein - Vice president, venture capital at BDC
Ela Borenstein

Vice President

View profile
About the company

Cytochroma is a clinical-stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD).

Your privacy

BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.

To find out more, consult our Policy on confidentiality.